Accumulation of p53 and expression of CD44 in human prostatic cancer and benign prostatic hyperplasia: An immunohistochemical study

British Journal of Urology

Volumn 77, Issue 3, 1996, Pages 441-444

  Xhang, X H ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Benign prostatic hyperplasia; CD44; Immunohistochemistry; p53; Prostatic cancer

Indexed keywords

HERMES ANTIGEN; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

EID: 0029875382     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1996.85721.x     Document Type: Article

References (24)

1. Levinc MF, Mümand J. Finlay CA. The p5 3 tumor suppressor gene. Nature 1991: 351: 453-6
2. Volgelstein B, Kinzler KW. p5 5 function and dysfunction. Cell 1992; 70: 523-6
3. Merler WE. Avignolo C. Baserga R. Role of the p5 3 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol Cell Bid 1984; 4: 276-81
4. flail PH. Lane DP. p53 in tumor pathology; can we trust immunohistochemistry? -revisited. / Pathol 1994; 172: 1-4
5. Picker LJ, Nakache M. Butcher EC. Monoclonal antibodies to human lymphocyte homoing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Bid 1989: 109: 927-38
6. Miyake K. Underbill CB. Eesley J. Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD 44 participates in hyaluronate recognition. J Exp Med 1990; 172: 69-75
7. Shtivelman E. Bishop JM. Expression of CD44 is repressed in neuroblastoma cells. MoJ Cell Bid 1991; 11: 5446-53
8. Gunthert U. Hofman M, Rudy W et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24
9. Rudy W. Hofmann M. Schwartz AR et al. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 1993; 53: 1262-8
10. Gleason DF and Veterans Administration Cooperation Urological Research Group. Histologie grading and clinical staging of prostate carcinoma In Tannenbaum M ed. Urologie Pathology: The Prostate. Philadelphia: Lea and Febiger. 1977: 171-97
11. Peterson RO. Urologie Pathology. Philadelphia: J.B. Lippincott. Philadelphia. 1986: 613-68
12. Voller HJ, Sugars LY. Pretlow T. Gelmann EP. p5 3 oncogene mutations in human prostate cancer specimens. / Urol 1994: 151: 492-5
13. Visakorpi T. Kallioniemi OP, Heikkinen A, Koivula T. Isola T. Small subgroup of aggressive, highly proliferative prostatic carcinoma defined by p53 accumulation. / Natl Cancer Inst 1992; 84: 883-7
14. Dinjens WNM. Weiden MMVD, Schroeder FH. Bosnian FT. Trapman J. Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer. Int }Cancer 1994: 56: 630-3
15. Aprikian AG. Sarkis AS. Fair WR. Zhang ZF, Fuks Z, Cordon-Cardo C. Immunohistochemical determination of pï 3 protein nuclear accumulation in prostatic adenocarcinoma. J L'rol 1994; 151: 1276-80
16. Henke RP. Kruger E. Ayhan N. Hubner D, Hammerer P. Huland H. Immunohistochemical detection of p53 protein in human prostatic cancer. / Ural 1994; 152: 1297-301
17. Fisher Cf. Gillett CE. Vojtesek B, Barnes DM. Millis RR. Problems with p 5 3 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation. Kr l Cancer 1994: 69: 26-31
18. Kawasaki Y. Monden T, Morimoto H et al. Immunohistochemical study of p53 expression in microwave fixed paraffin embedded sections of colorectal carcinoma and adenoma. Am ] Clin Pathol 1994; 97: 244-9
19. Heider KH. Hofmann M. Hors E et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. / Cell Biol 1993; 120: 227-33
20. Dali P. Heider KH. Hekele A et al. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 1994; 54: 3337-41
21. Penno MB. August JT. Baylin SB et al. Expression of CD44 in human lung tumors. Cancer Res 1994: 54: 1381-7
22. Eiu AY. Expression of CD44 in prostate cancer cells. Cancer Lett 1994: 76: 63-9
23. Kennel SJ, Lankford TK. Foote LJ. Shinpock SG. Stringer C. CD44 expression in murine tissues. / Cell Sei 1993: 104: 373-82
24. Fujita N. Yaegashi N. Ide Y et al. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymphvascular space involvement of cancer cells. Cancer Res 1994: 54: 3922-8